[email protected]
We established a quick response research team to monitor the impacts of global pandemic COVID19 on this market to keep our clients informed about latest data and changing strategies. The report will incorporate these insight and data factors. | × |
---|
Understand the COVID-19 Outbreak and its impact on global & regional businesses
request free proposal
Insights on a world turned upside down : Re-imagining
The post-COVID19 Business resilience & recovery
How effective strategies and business recovery plans are winning the race
request free proposal
Goldstein Market Intelligence help you navigate through the COVID-19 crisis,
we will provide you most relevant market insights on crisis management,
recovery strategy & business continuity.
2019-06-18
320
Global
Market Highlights
With the introduction of novel diagnostic tests medical outcomes related with organ transplants have improved significantly in past few years. Moreover, organ refusal rate can be reduced by matching the donor and receiver compatibility before transplantation. Traditional procedures in transplant diagnostics comprise analysis of human leukocyte antigen (HLA). HLA analysis is completed in high-throughput laboratories with a limited staff, which is time consuming. However, presence of molecular assay technologies, such as sequencing techniques and PCR-based assays has proved to be efficient and significantly boosted the growth of global transplant diagnostics market.
Further, government initiatives are more likely to encourage organ transplantation alongside with awareness initiatives for the same is strengthening the growth of the transplant diagnostics market. For instance, initiatives by the European Commission for organ harvesting have given rise to availability of donated organs. Obtainability of the European donor card and cumulative consciousness among people have also amplified organ donation rate in the region. Likewise, U.S. has witnessed substantial growth in organ donations due to rising awareness.
Also, many companies are working on different business strategies to take the advantage of this growing arket and to grasp the significant market share of this industry. For instance, CareDx stated in a filing with the Securities and Exchange Commission that it has inked a authorizing and commercialization agreement with Illumina for the international distribution, development, and commercialization rights to Illumina's next-generation sequencing transplant clinical application products.
As per the analysis of global transplant diagnostics market conducted by Goldstein Research is anticipated to register a CAGR of 6.5% during the forecast period. In terms of value, the global transplant diagnostics market is anticipated to reach a market valuation in excess of USD 1380.4 million by 2025 end.
Our report also provide with qualitative information on the factors mentioned below:
Key Players Mentioned In the Report
Abbott Laboratories, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-LA Roche, Ltd., Illumina, Inc., Immucor, Inc., Linkage Biosciences, Olerup SSp AB, Qiagen N.V., Sigma-Aldrich and Thermo Fisher Scientific, Inc.
Transplant diagnostics Market, By Components Type
Transplant diagnostics Market, By Technology
Transplant diagnostics Market, By Transplant Type
Transplant diagnostics Market, By Applications
Transplant diagnostics Market, By End-Users
Transplant diagnostics Market, By Region
North America held over 30.0% share in the global market in 2017 owing to high adoption of advanced techniques and diagnostic tools, higher healthcare expenditure, and availability of skilled professionals. Further, presence of major market players in U.S, target population, and strong healthcare infrastructure in the region further reinforced the dominance of this region.
On the other hand, government regulation such as the Organ Transplantation Act that enforces restraints on compensation policies for organ donors is adversely distressing the market. The prevailing demand and supply gap in organ donation and the accessibility of alternatives for heart and liver transplants are limiting the market growth.
A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements
OR Call Us:+1-646-568-7747Global Point of Care Testing (POCT) Devices Market Outlook 2024: Global Opportunity , Market Segmentation By Systems Basis, By Clinical Specialties & Diseases, By Areas of Use, By End User & by Region with Forecast 2017-2030
Global Home Healthcare Equipment Market Size , Share, By Device, By Distribution Channel, By End User & by Region with Forecast 2017-2030
Global Connected Healthcare Market Analysis by type, by function & by application with regional outlook and forecast to 2030
India In-Vitro Diagnostics (IVD) Market Outlook 2024, Global Opportunity and Demand Analysis, Market Forecast, 2016-2024
Global Connected Medical Device Market Outlook 2024, Global Opportunity and Demand Analysis, Market Forecast, 2016-2024